Clinical Operations

Aug 2, 2024 | cellandgene.com | Clinical Operations

By Tiffany Rice, Director, Clinical Operations The Functional Service Provider (FSP) model has emerged as a vital strategy in clinical research, offering pharmaceutical companies and research organizations the flexibility and efficiency needed to navigate the increasingly complex landscape of drug discovery and clinical trials.

Jun 21, 2024 | cellandgene.com | Raul P. Lima |Clinical Operations |inSeption Group

By Raul P. Lima, Executive Vice President, Clinical Operations, inSeption Group Gene therapy has existed for decades, but the field is not as mature as it may seem. Its unique pace, structure, and funding dynamics present distinct challenges. Raul P. Lima, Executive Vice President of Clinical Operations at inSeption Group, addresses these challenges in a series of articles.

Apr 18, 2024 | giiresearch.com | Clinical Operations

Bioprocess automation involves the utilization of automated systems to oversee and regulate the workflow of bioprocessing, which entails the utilization of living cells, organisms, or components to manufacture biological products such as biopharmaceuticals. Biopharmaceutical companies leverage bioprocess automation to enhance process control and optimization, improve product quality, reduce variability, increase throughput and efficiency, realize cost savings, and achieve scalability.

Apr 1, 2024 | onlinelibrary.wiley.com | Emily Nehme |Karen Smith |Colin Jones |Clinical Operations

The revised ambulance clinical response model implemented in Victoria was associated with a 93% step-increase in Triple Zero (000) calls undergoing secondary telephone triage, a 54% step-increase in calls not receiving an emergency ambulance, and a 28% step-decrease in calls allocated a Code 1 (lights and sirens) dispatch. These changes were associated with a 3.7% step-increase in Code 1 cases attended within 15 min.

Dec 26, 2023 | pharmaceuticalonline.com | Raul P. Lima |Clinical Operations |inSeption Group

Article | December 26, 2023 By Raul P. Lima, Executive Vice President, Clinical Operations, inSeption Group While gene therapy has been around for decades, the field is not as mature as many might imagine. Additionally, the pace, structure, and funding dynamics for gene therapy development are unique among treatment modalities.